CASOLARI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 7.531
AS - Asia 3.796
EU - Europa 2.548
SA - Sud America 558
Continente sconosciuto - Info sul continente non disponibili 165
AF - Africa 77
OC - Oceania 23
Totale 14.698
Nazione #
US - Stati Uniti d'America 7.356
SG - Singapore 1.433
CN - Cina 940
IT - Italia 807
DE - Germania 460
VN - Vietnam 437
BR - Brasile 429
UA - Ucraina 347
HK - Hong Kong 293
FI - Finlandia 238
TR - Turchia 216
GB - Regno Unito 202
FR - Francia 131
BD - Bangladesh 129
SE - Svezia 101
RU - Federazione Russa 85
JP - Giappone 83
CA - Canada 80
IN - India 67
MX - Messico 63
ID - Indonesia 44
AR - Argentina 43
NL - Olanda 41
PL - Polonia 36
ZA - Sudafrica 30
IQ - Iraq 23
EC - Ecuador 22
AU - Australia 18
BE - Belgio 17
PK - Pakistan 17
ES - Italia 15
CO - Colombia 14
MA - Marocco 14
MY - Malesia 14
VE - Venezuela 14
LT - Lituania 13
PH - Filippine 13
UZ - Uzbekistan 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
SA - Arabia Saudita 9
AT - Austria 8
NP - Nepal 8
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
CL - Cile 7
CR - Costa Rica 7
JM - Giamaica 7
PE - Perù 7
AL - Albania 6
KE - Kenya 6
AZ - Azerbaigian 5
EG - Egitto 5
HR - Croazia 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
IE - Irlanda 4
JO - Giordania 4
NZ - Nuova Zelanda 4
RO - Romania 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
GT - Guatemala 3
HU - Ungheria 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BB - Barbados 2
CG - Congo 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AM - Armenia 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
ET - Etiopia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
Totale 14.524
Città #
Singapore 870
Ashburn 754
Fairfield 641
San Jose 558
Woodbridge 556
Houston 393
Jacksonville 382
Santa Clara 348
Beijing 288
Hong Kong 288
Ann Arbor 281
Chandler 279
Munich 256
Seattle 241
Wilmington 220
Cambridge 205
Washington 201
Council Bluffs 196
Ho Chi Minh City 141
Izmir 138
Los Angeles 130
Helsinki 125
Nanjing 123
New York 117
Milan 113
Hanoi 101
Dallas 96
Princeton 86
Tokyo 79
Lauterbourg 73
Ferrara 72
Rome 62
Boardman 57
Chicago 45
San Diego 43
Mexico City 38
Shanghai 37
Toronto 36
Dearborn 35
Warsaw 33
Buffalo 32
Orem 32
Addison 31
São Paulo 31
Jakarta 30
Nanchang 29
Turku 28
Shenyang 27
Hebei 26
Tianjin 25
Brooklyn 22
Da Nang 21
London 21
Hefei 20
Jiaxing 20
Frankfurt am Main 19
Cardiff 18
Changsha 18
Haiphong 18
Montreal 18
Naples 18
Atlanta 17
Chennai 17
Turin 17
Bologna 16
Denver 16
Florence 16
Guangzhou 16
Moscow 16
Mountain View 16
San Francisco 16
Hải Dương 15
Kunming 15
Brussels 14
Johannesburg 14
Bremen 13
Parma 13
Boston 12
Manchester 12
Redwood City 12
Auburn Hills 11
Jinan 11
Rio de Janeiro 11
The Dalles 11
Belo Horizonte 10
Blackpool 10
Campinas 10
Jyväskylä 10
Philadelphia 10
Phoenix 10
Salt Lake City 10
Taizhou 10
Verona 10
Amsterdam 9
Baghdad 9
Curitiba 9
Dong Ket 9
Falls Church 9
Norwalk 9
Padua 9
Totale 9.721
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 545
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 352
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 349
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 333
Targeting Th2 cells in asthmatic airways 306
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 291
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 272
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 228
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 226
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 224
Activation of NF-kappaB transcription factor in asthma death 219
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 219
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 218
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 217
Cellule staminali e patologia polmonare dell’adulto 215
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 215
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 212
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 212
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 208
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 196
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 188
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 186
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 183
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 181
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 181
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 178
Mechanisms involved in lung cancer development in COPD 176
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 176
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 174
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 173
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6 172
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 170
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 169
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 169
Pathophysiology of viral-induced exacerbations of COPD 166
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 166
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 166
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 162
COPD pathology in the small airways 157
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 156
COPD immunopathology 156
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 154
New drugs targeting Th2 lymphocytes in asthma 151
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 148
Increased deposition of activated complement in peripheral lung vessels of smokers 147
SAA and lipid metabolism in IPF 145
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 137
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication 131
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 131
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 126
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 125
Trattamento personalizzato dei pazienti con BPCO in fase stabile 125
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 125
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 124
null 121
Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease 120
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 120
null 118
null 114
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 112
Expression of adenosine receptors in the peripheral lung from COPD patients. 110
Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and gro- production in bronchial epithelial cells. 109
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 109
Xanthine-Oxidase System Activation Is Required in Rhinovirus Induced Oxidant Production in Respiratory Epithelial Cells 109
Scavenger Receptor B1 involvement in COPD pathogenesis 108
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 108
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia. 106
Inhibition of PI-3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice 105
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κb and c-Jun N-terminal kinase activation 104
Definition and aetiology of infective exacerbations of COPD 103
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1 102
null 102
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease 102
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 100
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: patologia. 98
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 97
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 97
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations 96
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients 95
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 94
null 92
null 91
null 91
null 90
null 88
null 88
Ruolo delle infezioni virali nelle riacutizzazioni asmatiche. 82
null 81
null 81
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. 77
null 66
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study 64
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 58
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 57
Role of transcription factors in the pathogenesis of asthma and COPD 52
null 51
STAT3 and STAT6 activation in lung tissues correlates with inflammatory and clinical traits in COPD 50
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. 49
Totale 14.698
Categoria #
all - tutte 64.534
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.825
Totale 67.359


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022633 0 0 70 54 24 36 26 49 22 58 85 209
2022/2023731 91 21 25 92 120 107 32 61 95 3 54 30
2023/2024353 39 45 14 6 28 55 10 17 6 10 12 111
2024/20252.025 42 52 141 49 234 223 138 154 368 214 224 186
2025/20265.423 447 238 447 616 835 291 611 370 513 589 257 209
2026/2027655 186 307 162 0 0 0 0 0 0 0 0 0
Totale 14.698